Published in Aust N Z J Surg on January 01, 1995
Esophagectomy for carcinoma of the esophagus in the elderly: results of current surgical management. Ann Surg (1998) 1.45
Presence and persistence of nutrition-related symptoms during the first year following esophagectomy with gastric tube reconstruction in clinically disease-free patients. World J Surg (2010) 0.80
Functional outcome of gastrointestinal tract and quality of life after esophageal reconstruction of esophagus cancer. Saudi J Gastroenterol (2009) 0.77
Standardisation of spirometry. Eur Respir J (2005) 48.20
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
General considerations for lung function testing. Eur Respir J (2005) 7.99
A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells. J Virol (1988) 7.80
Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J (2005) 7.58
Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience. J Thorac Cardiovasc Surg (1988) 6.83
Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells. J Virol (1982) 4.74
A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell (1994) 4.70
A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J Virol (1993) 4.67
Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation (1993) 4.53
Analysis of a cluster of surgical failures. Application to a series of neonatal arterial switch operations. J Thorac Cardiovasc Surg (1994) 4.28
A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J Virol (1992) 4.12
Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation. J Clin Oncol (1998) 3.81
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J Virol (1987) 3.74
O-linked oligosaccharides are acquired by herpes simplex virus glycoproteins in the Golgi apparatus. Cell (1983) 3.73
Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol (1994) 3.71
Environmental tobacco smoke and cardiovascular disease. A position paper from the Council on Cardiopulmonary and Critical Care, American Heart Association. Circulation (1992) 3.47
Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin. J Virol (1987) 3.40
Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J Virol (1994) 3.39
Vesicular stomatitis virus and sindbis virus glycoprotein transport to the cell surface is inhibited by ionophores. Virology (1980) 3.13
Type-A influenza viruses isolated from wild free-flying ducks in California. Avian Dis (1974) 2.98
Noninvasive ventilation. N Engl J Med (1997) 2.82
Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol (1992) 2.67
Implementation and evaluation of an algorithm for isolation of patients with suspected pulmonary tuberculosis. Infect Control Hosp Epidemiol (1996) 2.62
Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res (1993) 2.61
Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J Virol (1995) 2.52
Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. N Engl J Med (1987) 2.37
Scanning fluorescence correlation spectroscopy. II. Application to virus glycoprotein aggregation. Biophys J (1986) 2.33
Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J (1996) 2.26
Identification and characterization of a novel herpes simplex virus glycoprotein, gK, involved in cell fusion. J Virol (1992) 2.21
Binding to cells of virosomes containing herpes simplex virus type 1 glycoproteins and evidence for fusion. J Virol (1984) 2.21
Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol (2001) 2.20
The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions. J Virol (1998) 2.14
Implementing clinical practice guidelines: a community-based audit of breast cancer treatment. Australian Capital Territory and South Eastern New South Wales Breast Cancer Treatment Group. Med J Aust (2000) 2.11
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med (1999) 2.08
Herpes simplex virus glycoprotein K promotes egress of virus particles. J Virol (1995) 2.04
Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches. Stat Med (2001) 2.04
The effect of waiting for radiotherapy for grade III/IV gliomas. Radiother Oncol (2000) 2.01
Steady-state and transient-state kinetic studies on the oxidation of 3,4-dimethoxybenzyl alcohol catalyzed by the ligninase of Phanerocheate chrysosporium Burds. J Biol Chem (1986) 1.99
Ebstein's anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol (1994) 1.95
Evaluation of a home based health record booklet. Arch Dis Child (1984) 1.93
Identification and characterization of the virion-induced host shutoff product of herpes simplex virus gene UL41. J Gen Virol (1992) 1.92
Cytoplasmic domain of herpes simplex virus gE causes accumulation in the trans-Golgi network, a site of virus envelopment and sorting of virions to cell junctions. J Virol (2001) 1.91
Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. J Immunol (1996) 1.88
Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response. J Exp Med (1998) 1.85
Natural history of supravalvular aortic stenosis and pulmonary artery stenosis. J Am Coll Cardiol (1990) 1.78
Effect of global system for mobile communication (gsm)-like radiofrequency fields on vascular permeability in mouse brain. Pathology (2001) 1.75
Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates. Heart (2006) 1.75
Driving and patients with brain tumours: a postal survey of neurosurgeons, neurologists and radiation oncologists. J Clin Neurosci (2004) 1.73
The misuse of mammography in the management of breast cancer revisited. Med J Aust (1989) 1.73
The natural and "unnatural" history of congenitally corrected transposition. Am J Cardiol (1990) 1.66
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. Clin Exp Allergy (2009) 1.66
The extracellular domain of herpes simplex virus gE is sufficient for accumulation at cell junctions but not for cell-to-cell spread. J Virol (2000) 1.65
Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. Health Technol Assess (2005) 1.64
Use of the Hasson cannula producing major vascular injury at laparoscopy. Surg Endosc (1999) 1.62
Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. Br J Cancer (2013) 1.60
Congenital heart disease in the neonate: results of surgical treatment. Arch Dis Child (1983) 1.59
Role of mannose-6-phosphate receptors in herpes simplex virus entry into cells and cell-to-cell transmission. J Virol (1995) 1.58
Herpes simplex virus glycoprotein D acquires mannose 6-phosphate residues and binds to mannose 6-phosphate receptors. J Biol Chem (1994) 1.57
Intracellular transport of herpes simplex virus gD occurs more rapidly in uninfected cells than in infected cells. J Virol (1985) 1.56
The ICP4 binding sites in the herpes simplex virus type 1 glycoprotein D (gD) promoter are not essential for efficient gD transcription during virus infection. J Virol (1992) 1.51
Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. J Infect (2011) 1.50
Antigenic and functional analysis of a neutralization site of HSV-1 glycoprotein D. Virology (1990) 1.49
Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes. J Virol (1987) 1.48
Prognosis after breast recurrence following conservative surgery and radiotherapy in patients with node-negative breast cancer. Br J Surg (1999) 1.45
Herpes simplex virus IgG Fc receptors induced using recombinant adenovirus vectors expressing glycoproteins E and I. Virology (1990) 1.45
Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocyte clones. Virology (1993) 1.44
Efficacy of iodine water purification tablets against Cryptosporidium oocysts and Giardia cysts. Wilderness Environ Med (1997) 1.44
Pleural mesothelioma resulting from exposure to amosite asbestos in a building. Respir Med (1989) 1.44
Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). Ann Oncol (2014) 1.44
Increased plasma beta-thromboglobulin in patients with coronary artery vein graft occlusion: response to low dose aspirin. J Am Coll Cardiol (1990) 1.44
Deletions in herpes simplex virus glycoprotein D define nonessential and essential domains. J Virol (1990) 1.44
Prioritization of radiotherapy in Australia and New Zealand. Australas Radiol (2005) 1.43
Radiation therapy: are we getting value for money? Clin Oncol (R Coll Radiol) (1995) 1.42
Surgical therapy for atrial tachycardia in adults. J Am Coll Cardiol (1989) 1.41
Outer membrane protein YadA of enteropathogenic yersiniae mediates specific binding to cellular but not plasma fibronectin. Infect Immun (1993) 1.41
Large-scale clustering of cDNA-fingerprinting data. Genome Res (1999) 1.40
An Australasian assessment of the basic treatment equivalent model derived from New South Wales data. Australas Radiol (1999) 1.39
Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial. Br J Cancer (2010) 1.39
Isolation of the Escherichia coli iron superoxide dismutase gene: evidence that intracellular superoxide concentration does not regulate oxygen-dependent synthesis of the manganese superoxide dismutase. Proc Natl Acad Sci U S A (1984) 1.39
Erroneous assumptions on use of isoflurane. J Am Vet Med Assoc (1991) 1.38
DNA commission of the international society for forensic genetics: guidelines for mitochondrial DNA typing. Forensic Sci Int (2000) 1.37
The experience of girls and young women with inherited bleeding disorders. Haemophilia (2013) 1.37
Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J Infect Dis (1993) 1.37
Fluorescence photobleaching recovery measurements reveal differences in envelopment of Sindbis and vesicular stomatitis viruses. Cell (1981) 1.36
Herpes simplex virus glycoprotein K is known to influence fusion of infected cells, yet is not on the cell surface. J Virol (1995) 1.34
Purification and properties of protocatechuate 3,4-dioxygenase from Pseudomonas putida. A new iron to subunit stoichiometry. J Biol Chem (1981) 1.34
Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J Virol (1998) 1.33
Finger wrinkling as a test of autonomic function. Br Med J (1977) 1.33
Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. Br J Pharmacol (1997) 1.32
Exercise responses in patients with congenital heart disease after Fontan repair: patterns and determinants of performance. J Am Coll Cardiol (1990) 1.31
Dilated cardiomyopathy in children: determinants of outcome. Br Heart J (1994) 1.31
Percutaneous balloon valvuloplasty for pulmonary valve stenosis in infants and children. Br Heart J (1985) 1.27
Absent or occult pulmonary artery. Br Heart J (1984) 1.27
Predictors of outcome in severely head-injured children. Crit Care Med (2001) 1.27
Pulmonary atresia and intact ventricular septum: surgical management based on a revised classification. Circulation (1982) 1.25
Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity. J Clin Oncol (1997) 1.24
Evidence for translational regulation of herpes simplex virus type 1 gD expression. J Virol (1984) 1.24
Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. Circulation (1991) 1.23